Kutsev Ozyoruk, PhD
Harvard Medical School
Kutsev Bengisu Ozyoruk
“Personalized medicine is an emerging field that aims to tailor medical treatments to individual patients based on their unique genetic, environmental, and lifestyle factors. However, the impact of gender inequality on the development and implementation of personalized medicine has received little attention. This review explores the ways in which gender inequality can affect personalized medicine, with a focus on three key areas: research, clinical practice, and policy.
First, we examine the impact of gender bias on research in personalized medicine. We discuss how the underrepresentation of women in clinical trials can limit the generalizability of findings and lead to ineffective or harmful treatments for women. We also highlight the importance of considering intersectionality – the interaction between gender and other social identities – in personalized medicine research.
Next, we discuss the effect of gender inequality on clinical practice. We explore how gender-based discrimination and stereotypes can influence the diagnosis, treatment, and management of diseases. We also examine how differences in health-seeking behaviors and social support networks can impact personalized medicine interventions.
Finally, we review the implications of gender inequality for personalized medicine policy. We discuss how policy decisions around funding, regulation, and reimbursement can affect the development and accessibility of personalized medicine, particularly for marginalized populations.
Overall, this review highlights the need for greater attention to gender inequality in personalized medicine. By recognizing and addressing the ways in which gender bias and discrimination can affect research, clinical practice, and policy, we can ensure that personalized medicine is truly personalized – that it takes into account the unique needs and experiences of all patients, regardless of their gender or other social identities.”